¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"cell network"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
6
¿µ¹®
ÇѱÛ
clear cell adenocarcinoma
Åõ¸í¼¼Æ÷»ù¾ÏÁ¾, Åõ¸í¼¼Æ÷¼±¾ÏÁ¾
clear cell carcinoma
Åõ¸í¼¼Æ÷¾ÏÁ¾
clear cell hidradenoma
Åõ¸í¼¼Æ÷¶¡»ùÁ¾
clear cell sarcoma
Åõ¸í¼¼Æ÷À°Á¾
columnar cell
¿øÁÖ¼¼Æ÷
committed cell
¾ô¸Ç¼¼Æ÷, ¼öÀÓ¼¼Æ÷
complex cell
º¹ÇÕ¼¼Æ÷
cone cell
¿ø»Ô¼¼Æ÷
cone cell layer
¿ø»Ô¼¼Æ÷Ãþ, ¿øÃß¼¼Æ÷Ãþ
connective tissue cell
°áÇÕÁ¶Á÷¼¼Æ÷
continuous cell line
¹«ÇÑÁõ½Ä¼¼Æ÷ÁÖ, ¿¬¼Ó°è´ë¼¼Æ÷ÁÖ
contractile fiber cell
¼öÃ༶À¯¼¼Æ÷
cover cell
µ¤°³¼¼Æ÷
crenated cell
Åé´ÏÀûÇ÷±¸
crescent cell anemia
Ãʽ´ÞÀûÇ÷±¸ºóÇ÷
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
6
¿µ¹®
ÇѱÛ
blood cell separator
Ç÷±¸ºÐ¸®±â
bone marrow-derived cell
°ñ¼öÀ¯·¡¼¼Æ÷
border cell
°æ°è¼¼Æ÷, ¼Ó°æ°è¼¼Æ÷
bristle cell
¾ï¼¾Åм¼Æ÷, °¸ð¼¼Æ÷
burr cell
¹«µòÅ鳯ÀûÇ÷±¸
cell bank
¼¼Æ÷ÀºÇà
nerve cell body
½Å°æ¼¼Æ÷ü
cell
¼¼Æ÷
cell culture
¼¼Æ÷¹è¾ç
cell cycle
¼¼Æ÷ÁÖ±â
cell death
¼¼Æ÷»ç
cell dedifferentiation
¼¼Æ÷¿ªºÐÈ
cell division
¼¼Æ÷ºÐ¿
cell envelope
¼¼Æ÷²®Áú
cell fusion
¼¼Æ÷À¶ÇÕ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
6
¿µ¹®
ÇѱÛ
Sertoli cell
½áÅ丮 ¼¼Æ÷
Sertoli cell only syndrome
½áÅ丮 ¼¼Æ÷ ÁõÈıº
Sezary cell
¼¼ÀÚ¸®¼¼Æ÷
T cell ; T lymphocyte ; thymus derived lymphocyte
T¼¼Æ÷ ; T¸²ÇÁ? ; Èä¼±À¯·¡¸²ÇÁ?
T cell activating factor
T¼¼Æ÷Ȱ¼ºÀÎÀÚ
T cell cooperation
T¼¼Æ÷Çùµ¿
T cell deficiency
T¼¼Æ÷°áÇÌ
T cell factor (TCF)
T¼¼Æ÷
T cell growth factor (TCGF, IL-2)
T¼¼Æ÷ Áõ½ÄÀÎÀÚ
T cell hybridoma
T¼¼Æ÷ ÇÏÀ̺긮µµ¸¶
T cell immunity
T¼¼Æ÷¸é¿ª
T cell leukemia
T¼¼Æ÷(¹éÇ÷º´
T cell lymphoma
T¼¼Æ÷¸²ÇÁÁ¾
T cell receptor
T¼¼Æ÷[Ç׿ø]¼ö¿ëü
T cell receptor gene
T¼¼Æ÷[Ç׿ø]¼ö¿ëü À¯ÀüÀÚ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
6
¿µ¹®
ÇѱÛ
sustentacular cell [sertoli cell]
¹öÆÀ¼¼Æ÷
abnormality of cell interaction
¼¼Æ÷»óÈ£ÀÛ¿ëÀÌ»ó
acantholytic cell
±Ø¼¼Æ÷ÇØ¸®¼¼Æ÷
acanthome a cellules claires => clear cell acanthoma
accessory cell
º¸Á¶¼¼Æ÷, ºÎ¼ö¼¼Æ÷
acidophilic cell
È£»ê¼º¼¼Æ÷
acinar cell
¼±Æ÷ ¼¼Æ÷(àÍøàá¬øà)
acinar cell
¼±¹æ¼¼Æ÷(¡á¬øà)
acinic cell carcinoma
¼±¹æ¼¼Æ÷¾ÏÁ¾(¡á¬øàäßðþ)
acinic cell tumor
¼±¹æ¼¼Æ÷Á¾(¡á¬øàðþ)
activation, polyclonal B cell
´Ù¼¼Æ÷±º B¼¼Æ÷Ȱ¼º, ¿©·¯¹«¸® B¼¼Æ÷Ȱ¼º
adamantinoid basal cell carcinoma
¹ý¶û Á¾¾ç(ÛöÕË ðþåÆ) ±âÀú¼¼Æ÷¾Ï(Ðñî¼á¬øàäß)
adcc(antibody dependent cell mediated cytotoxicity)
Ç×üÀÇÁ¸¼¼Æ÷¸Å°³¼¼Æ÷µ¶¼º(ù÷ô÷ëîðíá¬øàØÚË¿á¬øàÔ¸àõ)
adenoid basal cell carcinoma
¼±»ó(àÍßÒ) ±âÀú¼¼Æ÷¾Ï(Ðñî¼á¬øàäß)
adenoid squamous cell carcinoma
¼±»ó ÆíÆò »óÇǼ¼Æ÷(àÍßÒ ø·øÁ ß¾ù«á¬øà) ¾Ï
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
6
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
6
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
6
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
6
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
6
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
6
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½